Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 2 (February)

1. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure.
   Obstet Gynecol, 105(2): 246-54. [Abstract] [Full-text]
2. Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats.
   Pharmacol Res, 51(4): 359-65. [Abstract] [Full-text]
3. Role of arterial wall properties in the pathogenesis of systolic hypertension.
   Am J Hypertens, 18(1): 19S-22S. [Abstract] [Full-text]
4. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
   Am J Hypertens, 18(1): 3S-10S. [Abstract] [Full-text]
5. Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats.
   Free Radic Biol Med, 38(5): 589-96. [Abstract] [Full-text]
6. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.
   Arterioscler Thromb Vasc Biol, 25(2): 372. [Abstract] [Full-text]
7. Are platelets activated after a rapid, one-step density gradient centrifugation? Evidence from flow cytometric analysis.
   Clin Lab Haematol, 27(1): 75-7. [Abstract] [Full-text]
8. Albuminuria and hypertension are independently associated with circulating antipericyte autoantibodies in type 2 diabetic patients.
   Metabolism, 54(2): 188-93. [Abstract] [Full-text]
9. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
   Metabolism, 54(2): 157-64. [Abstract] [Full-text]
10. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.
    BMC Med Genet, 6: 4. [Abstract] [Full-text]
11. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.
    Hematol J, 5(7): 559-64. [Abstract] [Full-text]
12. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress.
    Circ Res, 96(2): 252-60. [Abstract] [Full-text]
13. Gonadal steroid regulation of renal injury in renal wrap hypertension.
    Am J Physiol Renal Physiol, 288(3): F513-20. [Abstract] [Full-text]
14. Antihypertensive effect of 5-HT1A agonist buspirone and 5-HT2B antagonists in experimentally induced hypertension in rats.
    Pharmacology, 73(3): 129-39. [Abstract] [Full-text]
15. Outcomes of renal artery angioplasty and stenting using low-profile systems.
    J Vasc Surg, 41(1): 46-52. [Abstract] [Full-text]
16. Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4 Q565E mutation.
    Am J Obstet Gynecol, 192(2): 598-603. [Abstract] [Full-text]
17. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives.
    Atherosclerosis, 178(2): 387-97. [Abstract] [Full-text]
18. Protein kinase C activation-induced increases of neural activity are enhanced in the hypothalamus of spontaneously hypertensive rats.
    Brain Res, 1033(2): 157-63. [Abstract] [Full-text]
19. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Cardiol Clin, 23(2): 139-52. [Abstract] [Full-text]
20. Pathogenesis and etiology of essential hypertension: role of dietary carbohydrate.
    Med Hypotheses, 64(4): 782-7. [Abstract] [Full-text]
21. Automated spoken dialogue system for hypertensive patient home management.
    Int J Med Inform, 74(2): 159-67. [Abstract] [Full-text]
22. Captopril improves cerebrovascular structure and function in old hypertensive rats.
    Br J Pharmacol, 144(3): 349-56. [Abstract] [Full-text]
23. Early altered renal sodium handling determined by lithium clearance in spontaneously hypertensive rats (SHR): role of renal nerves.
    Life Sci, 76(16): 1805-15. [Abstract] [Full-text]
24. Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile.
    Life Sci, 76(16): 1795-803. [Abstract] [Full-text]
25. Reduced renal reserve and increased cardiac output in adult female sheep uninephrectomized as fetuses.
    Kidney Int, 67(3): 822-8. [Abstract] [Full-text]
26. Treatment with tetrahydrobiopterin reduces blood pressure in male SHR by reducing testosterone synthesis.
    Am J Physiol Regul Integr Comp Physiol, 288(3): R733-6. [Abstract] [Full-text]
27. Renal contribution to increased clearance of exogenous growth hormone in obese hypertensive patients.
    J Clin Endocrinol Metab, 90(2): 795-9. [Abstract] [Full-text]
28. Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats.
    Am J Physiol Regul Integr Comp Physiol, 288(3): R615-22. [Abstract] [Full-text]
29. Markers of vascular function in hypertension due to Cushing's syndrome.
    Horm Metab Res, 37(1): 36-9. [Abstract] [Full-text]
30. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL.
    Curr Med Res Opin, 20(12): 1909-17. [Abstract] [Full-text]
31. Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid.
    Am J Physiol Heart Circ Physiol, 288(3): H1425-36. [Abstract] [Full-text]
32. Factors influencing the switch in the use of antihypertensive medications.
    Int J Clin Pract, 59(1): 85-91. [Abstract] [Full-text]
33. Efficacy and tolerability of candesartan cilexetil vs. amlodipine as assessed by home blood pressure in hypertensive patients.
    Int J Clin Pract, 59(1): 78-84. [Abstract] [Full-text]
34. Impact of systemic hypertension on the assessment of aortic stenosis.
    Heart, 91(3): 354-61. [Abstract] [Full-text]
35. The effects of hypertension on aortic valve stenosis.
    Heart, 91(3): 280-2. [Abstract] [Full-text]
36. Sodium-lithium countertransport and the Gly460-->Trp alpha-adducin polymorphism in essential hypertension.
    Clin Sci (Lond), 108(3): 231-6. [Abstract] [Full-text]
37. Cardiovascular death in women who had hypertension in pregnancy: a case-control study.
    BJOG, 112(3): 286-92. [Abstract] [Full-text]
38. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
    Eur Heart J, 26(5): 498-504. [Abstract] [Full-text]
39. A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension.
    J Pharmacol Exp Ther, 312(3): 1326-33. [Abstract] [Full-text]
40. Sleep complaints: snoring and daytime sleepiness in pregnant and pre-eclamptic women.
    Sleep Med, 6(2): 163-9. [Abstract] [Full-text]
41. Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: a pilot study.
    Diabetes Obes Metab, 7(2): 193-9. [Abstract] [Full-text]
42. Antithrombotic therapy in hypertension: a Cochrane Systematic review.
    J Hum Hypertens, 19(3): 185-96. [Abstract] [Full-text]
43. Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan.
    J Hum Hypertens, 19(3): 173-83. [Abstract] [Full-text]
44. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension.
    J Hum Hypertens, 19(3): 241-9. [Abstract] [Full-text]
45. The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage.
    J Hum Hypertens, 19(3): 211-7. [Abstract] [Full-text]
46. Associations between plasma antioxidants and hypertension in a community-based sample of 415 Australians aged 60-64.
    J Hum Hypertens, 19(3): 219-26. [Abstract] [Full-text]
47. Resistant hypertension in patients with chronic aortic dissection.
    J Hum Hypertens, 19(3): 227-31. [Abstract] [Full-text]
48. Diagnostic significance of transferrinuria and albumin-specific dipstick testing in primary care patients with elevated office blood pressure.
    J Hum Hypertens, 19(3): 205-9. [Abstract] [Full-text]
49. Promoting physical activity in Australian general practices: a randomised trial of health promotion advice versus hypertension management.
    Patient Educ Couns, 56(3): 283-90. [Abstract] [Full-text]
50. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
    Cardiovasc Res, 65(4): 921-9. [Abstract] [Full-text]
51. Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues.
    Regul Pept, 128(1): 1-5. [Abstract] [Full-text]
52. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Neurosci Lett, 376(3): 205-9. [Abstract] [Full-text]
53. Cardiovascular reactivity and family history of hypertension: a meta-analysis.
    Psychophysiology, 42(1): 125-31. [Abstract] [Full-text]
54. Nociception and baroreceptor stimulation in hypertension-prone men and women.
    Psychophysiology, 42(1): 83-91. [Abstract] [Full-text]
55. AT(2) receptors mediate tonic renal medullary vasoconstriction in renovascular hypertension.
    Br J Pharmacol, 144(4): 486-92. [Abstract] [Full-text]
56. Endothelium-dependent contractions in hypertension.
    Br J Pharmacol, 144(4): 449-58. [Abstract] [Full-text]
57. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity.
    J Mol Med, 83(2): 121-31. [Abstract] [Full-text]
58. Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment.
    Pediatr Blood Cancer, 44(4): 363-9. [Abstract] [Full-text]
59. Autonomic effects of expressive writing in individuals with elevated blood pressure.
    J Health Psychol, 10(2): 197-209. [Abstract] [Full-text]
60. Value of a standard urinary dipstick test for detecting microalbuminuria in patients with newly diagnosed hypertension.
    Swiss Med Wkly, 135(3): 57-61. [Abstract] [Full-text]
61. Angiotensin system inhibitors in a general surgical population.
    Anesth Analg, 100(3): 636-44, table of contents. [Abstract] [Full-text]
62. Effect of free radical scavenger (tempol) on intrarenal oxygenation in hypertensive rats as evaluated by BOLD MRI.
    J Magn Reson Imaging, 21(3): 245-8. [Abstract] [Full-text]
63. Comparison between three-dimensional volume-selective turbo spin-echo imaging and two-dimensional ultrasound for assessing carotid artery structure and function.
    J Magn Reson Imaging, 21(3): 282-9. [Abstract] [Full-text]
64. Renin inhibition: what are the therapeutic opportunities?
    J Am Soc Nephrol, 16(3): 592-9. [Abstract] [Full-text]
65. Ultradian but not circadian blood pressure rhythms correlate with renal dysfunction in children with chronic renal failure.
    J Am Soc Nephrol, 16(3): 746-54. [Abstract] [Full-text]
66. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation.
    Rheumatology (Oxford), 44(3): 372-7. [Abstract] [Full-text]
67. Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat.
    Biol Reprod, 72(3): 762-6. [Abstract] [Full-text]
68. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Clin Exp Pharmacol Physiol, 32(1): 76-85. [Abstract] [Full-text]
69. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
    Clin Exp Pharmacol Physiol, 32(1): 30-4. [Abstract] [Full-text]
70. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects.
    Hypertension, 45(3): 426-31. [Abstract] [Full-text]
71. Adducin polymorphism: detection and impact on hypertension and related disorders.
    Hypertension, 45(3): 331-40. [Abstract] [Full-text]
72. High heritability of ambulatory blood pressure in families of East African descent.
    Hypertension, 45(3): 445-50. [Abstract] [Full-text]
73. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging.
    Hypertension, 45(3): 374-9. [Abstract] [Full-text]
74. Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension.
    Hypertension, 45(3): 380-4. [Abstract] [Full-text]
75. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey.
    Hypertension, 45(3): 363-7. [Abstract] [Full-text]
76. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study.
    Hypertension, 45(3): 368-73. [Abstract] [Full-text]
77. Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition.
    Hypertension, 45(3): 432-7. [Abstract] [Full-text]
78. Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value.
    Hypertension, 45(3): 412-8. [Abstract] [Full-text]
79. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    J Am Coll Cardiol, 45(5): 712-9. [Abstract] [Full-text]
80. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    J Am Coll Cardiol, 45(5): 705-11. [Abstract] [Full-text]
81. Dietary intake of vitamin C and vitamin E and the development of hypertensive disorders of pregnancy.
    Eur J Obstet Gynecol Reprod Biol, 119(1): 67-71. [Abstract] [Full-text]
82. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation.
    Thromb Res, 115(5): 387-92. [Abstract] [Full-text]
83. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
    Thromb Res, 115(5): 359-66. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.